Development and Evaluation of DNA Vaccine Against Salmonid Alphavirus

• Main Author: Chang, Chia Jung
• Format: Article in Journal/Newspaper
• Language: English
• Published: 2021
• Subjects: Text; ddc:630; Salmonid alphavirus > DNA vaccine > Pancreas disease > Subcellular antigen expression > ELISA > Neutralizing activity > Histopathology; Norway; Sav’; Atlantic salmon
• Online Access: https://doi.org/10.1007/978-1-0716-1888-2_12; https://www.openagrar.de/receive/openagrar_mods_00075775; https://www.openagrar.de/servlets/MCRFileNodeServlet/openagrar_derivate_00058246/SD2021551.pdf; https://link.springer.com/protocol/10.1007/978-1-0716-1888-2_12

Despite vaccination, pancreas disease (PD) caused by salmonid alphavirus (SAV) has been the economically most important virus disease in salmon farming in Ireland, Scotland, and Norway. A vaccine based on DNA plasmid has been authorized to be used in Norwegian aquaculture since 2018. DNA vaccination of plasmids expressed subcellular viral proteins have been shown its particular protective effect against SAV3 that surface expression of the E2 protein with the whole viral protein construct, yielding a more effective vaccine. The chapter describes methods to design and test the sublocalization of expressed viral protein and the performance evaluation of vaccines against SAV3 infection in Atlantic salmon.